about
Clinical review: Imaging in ischaemic stroke--implications for acute managementPreventive antibacterial therapy in acute ischemic stroke: a randomized controlled trialRetrospective audit of the acute management of stroke in two district general hospitals in the uk.Blood glutathione S-transferase-π as a time indicator of stroke onsetIsolation of inflammatory cells from rat brain tissue after strokeAdvanced imaging to extend the therapeutic time window of acute ischemic stroke.Neuroprotective effects of propofol in acute cerebral injury.Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeCell adhesion molecules and ischemic strokeThe neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.The Stroke Oxygen Study (SO2S) - a multi-center, study to assess whether routine oxygen treatment in the first 72 hours after a stroke improves long-term outcome: study protocol for a randomized controlled trial.Alteplase for the treatment of acute ischaemic stroke: a NICE single technology appraisal; an evidence review group perspective.Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.Bilateral common carotid artery occlusion as an adequate preconditioning stimulus to induce early ischemic tolerance to focal cerebral ischemia.European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia.Surgical treatment of patients with unilateral cerebellar infarcts: clinical outcome and prognostic factors.Tissue-type plasminogen activator as a therapeutic target in stroke
P2860
Q33299284-11C5E65E-A358-4AD5-958B-EE9CFB8A4BACQ33334457-1DF3D4EF-D6D4-44FD-8C21-3706E156987AQ33950191-48C6700B-B741-478D-8E3C-E469FE6063F8Q34426843-4C4A023F-470D-4729-9CB8-DB36DC3866A9Q34432514-53078590-AF40-4A57-A165-FF9EA97EFEA0Q34573462-B839363A-0BCE-4F2B-83FE-017E04621296Q36951258-F72B6311-EE25-46E1-9ACD-1927C0E4685DQ36986490-8675CB78-1259-4891-99A8-2E49003402F9Q37280979-F36395D8-5ECB-42ED-9A8C-5F387C9FA6F1Q37282898-03A3AB3B-46A5-4550-B06D-150E7089970AQ37357487-9EE8F9AA-6267-4197-A2FB-A20C0EA23CB7Q37688403-3380CBA5-DF1A-4C54-8E02-1CF157F8E549Q38271386-118BB7DA-B08A-4F9D-BCA5-0FAEAD4BADFEQ38751348-C3D87285-006A-4232-8DC3-4E557314B91CQ42150578-CD661BD5-484F-46A7-BA0C-F3FD12E705B3Q48066036-2D0E37F2-3E52-4CC0-A5D1-E7B31B5CFC14Q48268410-9178D1CD-4B8B-47F6-A8DB-8EF8E1863AF8Q48769759-E121EFF3-04C5-4C72-99D8-000B2B6A240AQ48953523-DCF3F367-6393-4E7F-A0BA-054A243C09FEQ56336828-301B4EE3-BE8F-4134-A8DA-A423A8001A75
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Established treatments for acute ischaemic stroke.
@ast
Established treatments for acute ischaemic stroke.
@en
type
label
Established treatments for acute ischaemic stroke.
@ast
Established treatments for acute ischaemic stroke.
@en
prefLabel
Established treatments for acute ischaemic stroke.
@ast
Established treatments for acute ischaemic stroke.
@en
P1433
P1476
Established treatments for acute ischaemic stroke.
@en
P2093
Aslam M Khaja
James C Grotta
P304
P356
10.1016/S0140-6736(07)60154-8
P407
P577
2007-01-01T00:00:00Z